The New Jersey Alliance for Clinical and Translational Science at Rutgers received a $5 million NIH grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable communities in New Jersey.
It’s been seven months since COVID-19 was declared a global pandemic. Rutgers students and faculty discuss the new normal.
As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean.
Health officials can’t rely on a one-size-fits-all message when it comes to communicating with the public about a forthcoming COVID-19 vaccine, says Professor William Hallman, an experimental psychologist who uses scientific research to explore human behavior.
Human behavior is undermining efforts to curtail the spread of COVID-19, says School of Public Health dean and epidemiologist Perry N. Halkitis in a televised interview on CNN’s Erin Burnett OutFront nightly news program.
